<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="100690">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01738659</url>
  </required_header>
  <id_info>
    <org_study_id>UNIPA</org_study_id>
    <nct_id>NCT01738659</nct_id>
  </id_info>
  <brief_title>Estimated Echocardiographic Pulmonary Capillary Wedge Pressure in Heart Failure</brief_title>
  <official_title>Moderate Versus Low Sodium Diet Intake Effects on Estimated Echocardiographic Pulmonary Capillary Wedge Pressure During 12 Months of Follow up in Compensated Heart Failure Patients.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Palermo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ospedale G. F. Ingrassia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Palermo</source>
  <oversight_info>
    <authority>Italy: Ethics Committee</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study was to verify the effects of moderate versus low sodium intake on
      pulmonary capillary wedge pressure (PCWP), determined by Doppler echocardiography and tissue
      Doppler imaging in patients suffering from compensated heart failure.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      the study outcome is hospital readmission and mortality after 12 months of two different
      sodium diet.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2008</start_date>
  <completion_date type="Actual">September 2012</completion_date>
  <primary_completion_date type="Actual">December 2010</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <study_design>Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>number of hospital readmitted patients</measure>
    <time_frame>1 year</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>every six months we measure the PCWP by echocardiography</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>number of death</measure>
    <time_frame>1 year</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">143</enrollment>
  <condition>Heart Failure</condition>
  <arm_group>
    <arm_group_label>normal sodium diet (120 mmol/die)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>active comparator: low sodium diet (80 mmol/die)</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>normal sodium diet</intervention_name>
    <description>normal sodium diet (120 mmol/daily) for 1 year</description>
    <arm_group_label>normal sodium diet (120 mmol/die)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  compensated HF patients

        Exclusion Criteria:

          -  decompensated HF patients
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>pietro di pasquale, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>G.F. Ingrassia Hospital</affiliation>
  </overall_official>
  <verification_date>November 2012</verification_date>
  <lastchanged_date>November 27, 2012</lastchanged_date>
  <firstreceived_date>October 23, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Palermo</investigator_affiliation>
    <investigator_full_name>Gaspare Parrinello</investigator_full_name>
    <investigator_title>Associate Professor of Internal Medicine</investigator_title>
  </responsible_party>
  <keyword>sodium ,diuretics, PCWP</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
